-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
*For medical professionals only
A new chapter in ra combination therapy has begun and we are looking for the best partner
References[1]Ishiguro N, Yamamoto K, Katayama K, et al.
Concomitant iguratimod therapy in patients with active rheumatoid arthritis despite stable doses of methotrexate: a randomized, double-blind, placebo-controlled trial.
Mod Rheumatol[J].
2013, 23(3): 430-439.
[2] Hara M, Ishiguro N, Katayama K, et al.
Safety and efficacy of combination therapy of iguratimod with methotrexate for patients with active rheumatoid arthritis with an inadequate response to methotrexate: an open-label extension of a randomized, double-blind, placebo-controlled trial[J].
Mod Rheumatol.
2014, 24(3): 410-418.
Zhang Jiayong, Guo Jin, Shen Jie, et al.
Clinical observation of MTX combined with Ellamod in the treatment of refractory rheumatoid arthritis[J].
China Medical Guide, 2014(1): 98-99.
Ding Ling, He Shanzhi, Wang Min, et al.
Efficacy of Erarmod on Elderly Rheumatoid Arthritis and Its Bone Metabolism Analysis[J].
Jilin Medicine.
2019, 40(06): 1269-1270.
Dai Lu, Song Xinli, Qiu Xiaoming, et al.
Effect of Ellamod combined with leflunomide in the treatment of moderate and severe geriatric active rheumatoid arthritis[J].
Journal of Practical Clinical Medicine.
2019, 23(3): 73-77.
Tian Xinping, Liu Shengyun, Li Qin, et al.
Efficacy and safety comparison of Ellamod or leflunomide combined with methotrexate in the treatment of active rheumatoid arthritis: a multicenter, randomized, double-blind, double-analog-controlled clinical study[J].
2020, 24(3): 148-158.
Niu Min, Yan Meixi, Gao Jie, et al.
Effects of Ellamod and Leflunomide in the treatment of rheumatoid arthritis on bone metabolism and serum IgA, IgG and IgM in patients[J].
Hainan Medical Journal, 2021, 32(10): 1252-1255.
ZHANG Lingling.
Changes in bone metabolic indexes, clinical efficacy and safety of Ellamod before and after 24 weeks of treatment in patients with moderate to severe rheumatoid arthritis[J].
Contemporary Medicine, 2021, 27(21):52-54.
Cheng Baoxiang,Hu Xiaofang.
Efficacy of methotrexate in combination with elamold and hydroxychloroquine in the treatment of rheumatoid arthritis[J].
Primary Care Forum, 2021, 25(32): 4630-4631.
Liu Changlian, He Dongdong, Li Xiaoming, et al.
Efficacy of Ellamod in the treatment of rheumatoid arthritis and its effect on immuno-inflammatory factor levels and bone metabolism indexes in patients[J].
Shaanxi Medical Journal, 2020, 49(5): 603-607.
MA Ling.
Efficacy of Elamod combined with methotrexate in the treatment of rheumatoid arthritis[J].
Aesthetic Medicine, 2014, (9): 265-266.
[12] Nozaki Y, Oribe M, Tomita D, et al.
Iguratimod Versus Salazosulfapyridine in Rheumatoid Arthritis Patients with an Inadequate Response to Methotrexate: Adjusted with Propensity Score Matching[J].
Mod Rheumatol.
2022.
doi: 10.
1093/mr/roac060.
This article is only used to provide scientific information to healthcare professionals and does not represent the position of the
Platform.